During the past decade, NZOZ Lekarze Specjalisci conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NZOZ Lekarze Specjalisci" are "Allergic Rhinoconjunctivitis" (1 trials), "Asthma" (1 trials), "Bronchial Asthma" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "NZOZ Lekarze Specjalisci" in a lesser frequency.

Most popular intervention types in "NZOZ Lekarze Specjalisci" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (2 trials), "Placebo" (2 trials), "Oralgen" (1 trials), "beclomethasone dipropionate plus formoterol fumarate combination" (1 trials) and "budesonide plus formoterol combination" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Lekarze Specjalisci" are 4 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Lekarze Specjalisci". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in NZOZ Lekarze Specjalisci, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Lekarze Specjalisci, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".